Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Tong Ren Tang Technologies Co ( (HK:1666) ) has provided an announcement.
Tong Ren Tang Technologies Co. Ltd. announced that its subsidiary, Beijing Tong Ren Tang Chinese Medicine Company Limited, has received a traditional medicine registration license from Cambodia’s Ministry of Health. This license allows the sale of ‘Tong Ren Tang Angong Niuhuang Wan’ in Cambodia, facilitating the expansion of the company’s distribution channels and market presence in the region. While this development is beneficial for market expansion, it is not expected to have a significant immediate impact on the company’s overall operations or performance.
More about Tong Ren Tang Technologies Co
Tong Ren Tang Technologies Co. Ltd. is a joint stock company incorporated in China, primarily engaged in the production and sale of traditional Chinese medicines. The company focuses on expanding its market presence through its subsidiaries, including Beijing Tong Ren Tang Chinese Medicine Company Limited.
Average Trading Volume: 1,571,600
Technical Sentiment Signal: Sell
Current Market Cap: HK$6.21B
See more data about 1666 stock on TipRanks’ Stock Analysis page.